YFPHR has asked the MHRC to direct the state authority to regulate and maintain a standard cost for the COVID-19 test.

the anticipated winter surge of Covid-19 and possible cases of re-infections indicate that the scenario of Covid-19 could change across the world and India, including Manipur

Cipla and Hetero Labs have received approval to sell generic versions of remdesivir, developed by Gilead Sciences Inc, in India